Recorded fact · drug.label_indication
drug.label_indication for benralizumab|eosinophilic-granulomatosis-with-polyangiitis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 7a4a8b68 resolves to.
The record
| Fact id | 7a4a8b683f2a2b2420f8b03e |
|---|---|
| Entity | drug: benralizumab|eosinophilic-granulomatosis-with-polyangiitis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260513 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
Shown with dashes as hyphens. SHA-256 of the exact stored quote: e1680b1ffc736064d2b61f21cfa5cf21db9b87302f5c86ba3c4720d34ee06724.
The value
{
"ingredient": "Benralizumab",
"conditionId": "eosinophilic-granulomatosis-with-polyangiitis",
"conditionName": "Eosinophilic granulomatosis with polyangiitis",
"matchedAlias": "eosinophilic granulomatosis with polyangiitis",
"context": "indication",
"brand": "FASENRA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "da6aca1a-19ed-44a4-abb7-696c7d58b784",
"labelEffectiveTime": "20260513",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 18bb2b9bc3b85b54a31e92c1a5b30fad7b386dd6add689727ced08b98d902ed3.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.